In 2014, Riga Fertiliser Terminal (RFT), URALCHEM’s own terminal for fertilizer handling in Riga received 1.75 million tons and shipped 1.71 million tons of products. A total of 87 vessels of various deadweight tonnage were loaded at the terminal in the last year.
In an interview for Vedomosti, URALCHEM CEO Dmitry Konyaev discusses current fertiliser market outlook, dealing with European customers amid sanction imposed restrictions, story behind Uralkali stake acquisition, future of Voskresensk Mineral Fertilisers and URALCHEM’s upcoming projects.
Revenue in the reporting period amounted to 52.66 bln RUB, compared to 56.26 bln RUB in January-September 2013. Operating profit increased to 15.45 bln RUB, compared to 14.62 bln RUB for the nine months of 2013. Adjusted EBITDA increased to 18.27 bln RUB, compared to 17.31 bln RUB in the same period of 2013. Net loss comprised 19.17 bln RUB, compared to profit of 10.08 bln RUB in the same period of 2013.
Revenue amounted to 36.54 bln RUB, compared to 40.06 bln RUB in the first half of 2013. Operating profit amounted to 9.70 bln RUB, compared with 12.22 bln RUB in the first half of 2013. Adjusted EBITDA comprised 11.57 bln RUB, compared to 14.01 bln RUB in the first half of 2013. Net profit amounted to 1.23 bln RUB, compared to 8.02 bln RUB in the first half of 2013.
Ventamonjaks is the largest liquid ammonia transhipment terminal in the Baltic Sea. It has an annual capacity of 1 million tonnes and is located in the ice-free port of Ventspils. URALCHEM’s subsidiary, Uralchem Freight limited, acted on behalf of URALCHEM as a party to the transaction and became the owner of 55% of the shares in the company, which has 100% shares in SIA Ventamonjaks.
A financial leasing contract was signed by URALCHEM-TRANS (part of URALCHEM) and Alpha Leasing. The deal amounted to about 500 million roubles.
Revenue decreased to 72.15 bln RUB, compared to 75.33 bln RUB in 2012. Operating profit amounted to 16.5 bln RUB, compared with 22.73 bln RUB in 2012. Adjusted EBITDA comprised 20.12 bln RUB, compared to 25.99 bln RUB in 2012.
In 2013 URALCHEM’s investments in development reached $174 million, an increase of 5.5% compared to the previous year.
In 2013, the URALCHEM Group increased funding for social and charitable programmes to 288 million roubles. It was an increase of 24% compared with 2012. Compared with 2011, the volume of allocated funds increased by more than three times.
URALCHEM OJSC announces the completion of its acquisition of shares in Uralkali (MISEX: URKA; LSE: URKA). As a result of the deal URALCHEM now controls 19.99% of Uralkali’s share capital.